Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New quinazoline sulfonamide derivatives as potential anticancer agents: Identifying a promising hit with dual EGFR/VEGFR-2 inhibitory and radiosensitizing activity
Mostafa M. Ghorab, Aiten M. Soliman, Khaled El‐Adl, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106791-106791
Closed Access | Times Cited: 23

Showing 23 citing articles:

Supramolecular complex catalyzed green synthesis of 9-(2-Ethylhexyl) carbazole: Structural, optical and DFT investigations
Priyanka Behera, T. Jaison Jose, D. S. Ramakrishna, et al.
Journal of Molecular Structure (2024) Vol. 1308, pp. 138089-138089
Closed Access | Times Cited: 20
Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)
Heba T. Abdel‐Mohsen, Manal M. Anwar, Nesreen S. Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 875-875
Open Access | Times Cited: 9
Rational design, docking, syntheses, ADMET and cytotoxicity assessments of iodoquinazoline derivatives as inhibitors of EGFRT790M and VEGFR-2
Ahmed K. B. Aljohani, Marwa Alsulaimany, Omar M. Alatawi, et al.
Journal of Molecular Structure (2025), pp. 141634-141634
Closed Access
Design and Synthesis of Novel Thiazolo[5,4-b]pyridine Derivatives as Potent and Selective EGFR-TK Inhibitors Targeting Resistance Mutations in Non-Small Cell Lung Cancer
Avinash S. Borude, Santosh Rangnath Deshmukh, Shailee V. Tiwari, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116727-116727
Closed Access | Times Cited: 4
Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFRWT and EGFRT790M: design, synthesis, ADMET and molecular docking
Ahmed K. B. Aljohani, Khaled El‐Adl, Basmah Almohaywi, et al.
RSC Advances (2024) Vol. 14, Iss. 12, pp. 7964-7980
Open Access | Times Cited: 3
Exploration of the VEGFR-2 inhibition activity of phthalazine derivatives: design, synthesis, cytotoxicity, ADMET, molecular docking and dynamic simulation
Hatem Hussein Bayoumi, Mohamed‐Kamal Ibrahim, Mohammed A. Dahab, et al.
RSC Advances (2024) Vol. 14, Iss. 30, pp. 21668-21681
Open Access | Times Cited: 2
Rationale, in silico docking, ADMET profile, design, synthesis and cytotoxicity evaluations of phthalazine derivatives as VEGFR-2 inhibitors and apoptosis inducers
Hatem Hussein Bayoumi, Mohamed‐Kamal Ibrahim, Mohammed A. Dahab, et al.
RSC Advances (2024) Vol. 14, Iss. 37, pp. 27110-27121
Open Access | Times Cited: 2
Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: Design, synthesis, molecular docking and anticancer evaluations
Abeer A. Mohamed, Sanadelaslam S. A. El‐Hddad, Ahmed K. B. Aljohani, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107062-107062
Closed Access | Times Cited: 7
Utility of sulfachloropyridazine in the synthesis of novel anticancer agents as antiangiogenic and apoptotic inducers
Sally S. Zahran, Fatma A. Ragab, Aiten M. Soliman, et al.
Bioorganic Chemistry (2024) Vol. 148, pp. 107411-107411
Closed Access | Times Cited: 1
Unveiling the Therapeutic Potential of Quinazolinone Derivatives in Cancer Treatment: A Comprehensive Exploration
Jasneet Kaur, Sukhmeet Kaur, Muskan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 32
Closed Access | Times Cited: 1
Design, synthesis, docking, ADMET and anticancer evaluations of N-alkyl substituted iodoquinazoline derivatives as dual VEGFR-2 and EGFR inhibitors
Marwa Alsulaimany, Khaled El‐Adl, Ahmed K. B. Aljohani, et al.
RSC Advances (2023) Vol. 13, Iss. 51, pp. 36301-36321
Open Access | Times Cited: 5
Design, Synthesis, and Biological Evaluation of Novel Quinazoline Derivatives Possessing a Trifluoromethyl Moiety as Potential Antitumor Agents
M Chen, Sha Cheng, Xing Dai, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 5
Closed Access | Times Cited: 1
Exploration of cytotoxicity of iodoquinazoline derivatives as inhibitors of both VEGFR‐2 and EGFRT790M: Molecular docking, ADMET, design, and syntheses
Marwa Alsulaimany, Sanadelaslam S. A. El‐Hddad, Zuhir S. M. Akrim, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Open Access | Times Cited: 1
Synthesis of Novel Gefitinib-Conjugated 1,2,3-Triazole Derivatives and Their Effect of Inducing DNA Damage and Apoptosis in Tumor Cells
Junfei Wu, Xu Huang, Shan Lu, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5438-5438
Open Access | Times Cited: 1
Discovery of novel octahydroquinazoline scaffolds endowed with dual inhibition of tubulin polymerization/Eg5 against HCC: Apoptotic and radio-chemotherapeutic studies
Mohammed K. Abdelhameid, Ehab S. Taher, Mohammed A. Hara, et al.
Bioorganic Chemistry (2024) Vol. 148, pp. 107449-107449
Closed Access
Design and Synthesis of Novel Thiazolo[5,4-B]Pyridine Derivatives as Potent and Selective Egfr-Tk Inhibitors Targeting Resistance Mutations in Non-Small Cell Lung Cancer
Avinash S. Borude, Santosh Rangnath Deshmukh, Shailee V. Tiwari, et al.
(2024)
Closed Access
A Review of Recent Progress on the Anticancer Activity of Heterocyclic Compounds
Beena Negi, Aarshiya Kwatra
SynOpen (2024) Vol. 08, Iss. 03, pp. 185-210
Open Access
Sulfonyl-acetohydrazide derivatives as juvenile hormone mimics to be insect growth regulators
Neetika Kumari, Manisha Chaudhary, Pamita Awasthi
Bioorganic Chemistry (2024) Vol. 153, pp. 107781-107781
Closed Access
IN SILICO STUDY OF THE MECHANISM OF ANTIСANCER ACTIVITY OF (E)-2-((5-(3-(2-FLUOROPHENYL)ACRYLOYL)-4-METHYLTHIAZOL-2-YL)AMINO)ISOINDOLINE-1,3-DIONE (LES-6489)
O.-M. V. Fedusevych
Фармацевтичний часопис (2024), Iss. 2, pp. 5-13
Open Access
Novel quinazolin-4-one based derivatives bearing 1,2,3-triazole and glycoside moieties as potential cytotoxic agents through dual EGFR and VEGFR-2 inhibitory activity
Adel A.‐H. Abdel‐Rahman, Mohamed N. El-Bayaa, Asmaa Sobhy, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Halogen‐based quinazolin‐4(3H)‐one derivatives as MCF‐7 breast cancer inhibitors: Current developments and structure–activity relationship
Rachana Upadhyay, P. K. Tandel, Amit B. Patel
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
Rhodanine–Piperazine Hybrids as Potential VEGFR, EGFR, and HER2 Targeting Anti-Breast Cancer Agents
Jacek Szczepański, Dmytro Khyluk, Agnieszka Korga-Plewko, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12401-12401
Open Access
Design and Discovery of New Dual Carbonic Anhydrase IX and VEGFR‐2 Inhibitors Based on the Benzenesulfonamide‐Bearing 4‐Thiazolidinones/2,4‐Thiazolidinediones Scaffold
Merve Zengin, Oya Ünsal Tan, Suna Sabuncuoğlu, et al.
Drug Development Research (2024) Vol. 85, Iss. 8
Closed Access
Page 1

Scroll to top